Steven P James's Net Worth
$891 Thousand
Who is Steven P James?
Steven P James does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncothyreon Inc., EXELIXIS INC, Allakos Inc., and Ocera Therapeutics, Inc..
SEC CIK
Steven P James's CIK is 0001243025
Past Insider Trading and Trends
2017 was Steven P James's most active year for acquiring shares with 6 total transactions. Steven P James's most active month to acquire stocks was the month of May. 2017 was Steven P James's most active year for disposing of shares, totalling 12 transactions. Steven P James's most active month to dispose stocks was the month of February. 2021 saw Steven P James paying a total of $3,937.50 for 15,200 shares, this is the most they've acquired in one year. In 2021 Steven P James cashed out on 15,000 shares for a total of $858,255.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncothyreon Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.68K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +14.97% | 1.78K |
$3.94 | -$2,340.36 | 13.68K |
Sep 24
| |||
Form 4
| +133.12% | 6.79K |
$3.78 | -$8,561.70 | 11.9K |
Jun 24
| |||
Form 4
| +46.13% | 1.61K |
$3.34 | -$1,793.58 | 5.1K |
Jun 9 - Jun 12
| |||
Form 4
|
∞
| 3.49K |
$4.35 | -$5,063.40 | 3.49K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
EXELIXIS INC (EXEL) Snapshot price: $25.13
Sr VP, Commercial Ops
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Allakos Inc. (ALLK) Snapshot price: $0.648
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
$54.33 | -$430,380.00 |
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
$61.09 | -$423,937.50 | 3.5K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ocera Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.50K |
$1.52 | -$19,000.00 |
0
|
Dec 11
| |||
Form 4
|
∞
| 12.5K |
—
|
—
| 12.5K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |